Cell proliferation in human epiretinal membranes: Characterization of cell types and correlation with disease condition and duration

Molecular Vision

Volumn 17, Issue , 2011, Pages 1794-1805

  Oberstein, Sarit Y Lesnik ^a   Byun, Jiyun ^c   Herrera, Diego ^b   Chapin, Ethan A ^b   Fisher, Steven K ^b   Lewis, Geoffrey P ^b  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c MAYACHITRA INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; MONOCLONAL ANTIBODY; PARAFORMALDEHYDE;

ANTIBODY LABELING; ARTICLE; CELL COUNT; CELL DIVISION; CELL LABELING; CELL PROLIFERATION; CELL TYPE; CLINICAL ARTICLE; CONFOCAL LASER MICROSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIABETIC RETINOPATHY; DISEASE DURATION; DISEASE SEVERITY; EPIRETINAL MEMBRANE; FEMALE; GLIA CELL; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; MALE; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DETACHMENT; RICINUS COMMUNIS; TISSUE FIXATION; VITRECTOMY; VITREORETINOPATHY;

CELL PROLIFERATION; CYTOSKELETAL PROTEINS; DIABETIC RETINOPATHY; EPIRETINAL MEMBRANE; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; HUMANS; IMMUNOHISTOCHEMISTRY; KI-67 ANTIGEN; MALE; MICROSCOPY, FLUORESCENCE; NEUROGLIA; RETINA; RETINAL DETACHMENT; RETINAL PIGMENT EPITHELIUM; TIME FACTORS; VIMENTIN; VITRECTOMY; VITREORETINOPATHY, PROLIFERATIVE; VITREOUS BODY;

EID: 79960703328     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. McCarty DJ, Mukesh BN, Chikani V, Wang JJ, Mitchell P, Taylor HR, McCarty CA. Prevalence and associations of epiretinal membranes in the visual impairment project. Am J Ophthalmol 2005; 140:288-94.
2. Uemura A, Ideta H, Nagasaki H, Morita H. Ito k. Macular pucker after retinal detachment surgery. Ophthalmic Surg 1992; 23:116-9.
3. Machemer R. Massive periretinal proliferation: a logical approach to therapy. Trans Am Ophthalmol Soc 1977; 75:556-86.
4. Hiscott PS, Grierson I, McLeod D. Natural history of fibrocellular epiretinal membranes: a quantitative, autoradiographic, and immunohistochemical study. Br J Ophthalmol 1985; 69:810-23.
5. Gilbert C, Hiscott P, Unger W, Grierson I, McLeod D. Inflammation and the formation of epiretinal membranes. Eye (Lond) 1988; 2:S140-56.
6. Kampik A, Kenyon KR, Michels RG, Green WR, de la Cruz ZC. Epiretinal and vitreous membranes, a comparative study of 56 cases. Arch Ophthalmol 1981; 99:1445-54.
7. Morino I, Hiscott P, McKechnie N, Grierson I. Variation in epiretinal membrane components with clinical duration of proliferative tissue. Br J Ophthalmol 1990; 74:393-9.
8. Vinores SA, Campochiaro PA, Conway BP. Ultrastructural and electron-immunocytochemical characterization of cells in epiretinal membranes. Invest Ophthalmol Vis Sci 1990; 31:14-28.
9. Baudouin C, Brignole F, Bayle J, Fredj-Reygrobellet D, Lapalus P, Gastaud P. Class II histocompatibility antigen expression by cellular components of vitreous and subretinal fluid in proliferative vitreoretinopathy. Invest Ophthalmol Vis Sci 1991; 32:2065-72.
10. Heidenkummer HP, Kampik A. Immunohistochemical localisation of epidermal growth factor receptor in human epiretinal membrane. Graefes Arch Clin Exp Ophthalmol 1991; 229:492-6.
11. Heidenkummer HP, Kampik A. Proliferative activity and immunohistochemical cell differentiation in human epiretinal membranes. Ger J Ophthalmol 1992; 1:170-5.
12. Zhang X, Barile G, Chang S, Hays A, Pachydaki S, Schiff W, Sparrow J. Apoptosis and cell proliferation in proliferative retinal disorders: PCNA, Ki-67, caspase-3, and PARP expression. Curr Eye Res 2005; 30:395-403.
13. Van Horn DL, Aaberg TM. 344 Machemer R, Fenzl R. Glial cell proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 1977; 84:383-93.
14. Machemer R, van Horn D, Aaberg TM. Pigment epithelial proliferation in human retinal detachment with massive periretinal proliferation. Am J Ophthalmol 1978; 85:181-91.
15. Heidenkummer HP, Kampik A, Petrovski B. Proliferative activity in epiretinal membranes. The use of the monoclonal antibody Ki-67 in proliferative vitreoretinal diseases. Retina 1992; 12:52-8.
16. Jerdan JA, Pepose JS, Michels RG, Hayashi H, de Bustros S, Sebag M, Glaser BM. Proliferative vitreoretinopathy membranes. An immunohistochemical study. Ophthalmology 1989; 96:801-10.
17. Lewis GP, Sethi CS, Carter KM, Charteris DG, Fisher SK. Microglial cell activation following retinal detachment: a comparison between species. Mol Vis 2005; 11:491-500.
18. Gerdes J, Schwab U, Lemke H, Stein H. Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation. Int J Cancer 1983; 31:13-20.
19. Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133:1710-5.
20. Schlüter C, Duchrow M, Wohlenberg C, Becker MH, Key G, Flad HD, Gerdes J. The cell proliferation associated antigen of antibody Ki-67: A very large, ubiquitous nuclear protein with numerous repeated elements, representing a new kind of cell cycle maintaining proteins. J Cell Biol 1993; 123:513-22.
21. Tsanou E, Ioachim E, Stefaniotou M, Gorezis S, Charalabopoulos K, Bagli H, Peschos D, Psilas K, Agnantis NJ. Immunohistochemical study of angiogenesis and proliferative activity in epiretinal membranes. Int J Clin Pract 2005; 59:1157-61.
22. Ioachim E, Stefaniotou M, Gorezis S, Tsanou E, Psilas K, Agnantis NJ. Immunohistochemical study of extracellular matrix components in epiretinal membranes of vitreoproliferative retinopathy and proliferative diabetic retinopathy. Eur J Ophthalmol 2005; 15:384-91.
23. Hamilton CW, Chandler D, Klintworth GK, Machemer R. A transmission and scanning electron microscopic study of surgically excised preretinal membrane proliferations in diabetes mellitus. Am J Ophthalmol 1982; 94:473-88.
24. Hiscott P, Gray R, Grierson I, Gregor Z. Cytokeratin-containing cells in proliferative diabetic retinopathy membranes. Br J Ophthalmol 1994; 78:219-22.
25. Fisher SK, Erickson PA, Lewis GP, Anderson DH. Intraretinal proliferation induced by retinal detachment. Invest Ophthalmol Vis Sci 1991; 32:1739-48.
26. Geller SF, Lewis GP, Anderson DH, Fisher SK. Use of the MIB-1 antibody for detecting proliferating cells in the retina. Invest Ophthalmol Vis Sci 1995; 36:737-44.
27. Fisher SK, Lewis GP, Lindberg KA, Verardo MR. Cellular remodeling in mammalian retina: results from studies of experimental retinal detachment. Prog Retin Eye Res 2005; 24:395-431.
28. Baudouin C, Gordon WC, Fredj-Reygrobellet D, Baudouin F, Peyman G, Gastaud P, Bazan NG. Class II antigen expression in diabetic preretinal membranes. Am J Ophthalmol 1990; 109:70-4.
29. Baudouin C, Fredj-Reygrobellet D, Gordon WC, Baudouin F, Peyman G, Lapalus P, Gastaud P, Bazan NG. Immunohistologic study of epiretinal membranes in proliferative vitreoretinopathy. Am J Ophthalmol 1990; 110:593-8.
30. Charteris DG, Hiscott P, Grierson I, Lightman SL. Proliferative vitreoretinopathy. Lymphocytes in epiretinal membranes. Ophthalmology 1992; 99:1364-7.
31. Charteris DG, Hiscott P, Robey HL, Gregor ZJ, Lightman SL, Grierson I. Inflammatory cells in proliferative vitreoretinopathy subretinal membranes. Ophthalmology 1993; 100:43-6.
32. Tang S, Scheiffarth O, Thurau SR, Wildner G. Cells of the immune system and their cytokines in epiretinal membranes and in the vitreous of patients with proliferative diabetic retinopathy. Ophthalmic Res 1993; 25:177-85.
33. Foos RY. Vitreoretinal juncture; epiretinal membranes and vitreous. Invest Ophthalmol Vis Sci 1977; 16:416-22.